Cardioprotective therapeutics--drugs used in hypertension, hyperlipidaemia, thromboembolism, arrhythmias, the postmenopausal state and as anti-oxidants.
作者信息
Kendall M J, Rajman I, Maxwell S R
机构信息
Department of Medicine, Queen Elizabeth Hospital, Edgbaston, Birmingham, UK.
出版信息
Postgrad Med J. 1994 May;70(823):329-43. doi: 10.1136/pgmj.70.823.329.
Abstract
摘要
相似文献
1
Cardioprotective therapeutics--drugs used in hypertension, hyperlipidaemia, thromboembolism, arrhythmias, the postmenopausal state and as anti-oxidants.
Postgrad Med J. 1994 May;70(823):329-43. doi: 10.1136/pgmj.70.823.329.
2
[Long-term drug prevention of cardiovascular diseases (methodological aspects)].
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR. 1983;6(2):103-7.
3
Evidence supporting secondary prevention strategies.
Curr Opin Cardiol. 1999 Jul;14(4):303-9. doi: 10.1097/00001573-199907000-00005.
4
[ALLHAT [Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial]].
Nihon Rinsho. 2001 Mar;59 Suppl 3:393-7.
5
Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT): practical implications.
Hypertension. 2003 May;41(5):1006-9. doi: 10.1161/01.HYP.0000070905.09395.F6. Epub 2003 Apr 14.
6
[New cardiovascular-active drugs].
Z Arztl Fortbild (Jena). 1984;78(19):797-800.
7
ALLHAT, or the soft science of the secondary end point.
Ann Intern Med. 2004 Jul 6;141(1):77. doi: 10.7326/0003-4819-141-1-200407060-00023.
8
[Hypertension in postmenopausal women].
Duodecim. 2002;118(1):25-30.
9
10
[Primary prevention of coronary disease with drugs].
Rev Prat. 1998 Jun 15;48(12):1281-2.
引用本文的文献
1
Cardioprotective therapeutics--drugs used in hypertension, hyperlipidaemia, thromboembolization, arrhythmias, postmenopausal state and as anti-oxidants.
Postgrad Med J. 1994 Oct;70(828):767-8. doi: 10.1136/pgmj.70.828.767.
本文引用的文献
1
Vitamin E consumption and the risk of coronary heart disease in men.
N Engl J Med. 1993 May 20;328(20):1450-6. doi: 10.1056/NEJM199305203282004.
2
Vitamin E consumption and the risk of coronary disease in women.
N Engl J Med. 1993 May 20;328(20):1444-9. doi: 10.1056/NEJM199305203282003.
3
Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. The Atherosclerosis Risk in Communities Study Investigators.
N Engl J Med. 1993 Apr 15;328(15):1069-75. doi: 10.1056/NEJM199304153281501.
4
Management of hyperlipidaemia: guidelines of the British Hyperlipidaemia Association.
Postgrad Med J. 1993 May;69(811):359-69. doi: 10.1136/pgmj.69.811.359.
5
Cardiovascular health and disease in women.
N Engl J Med. 1993 Jul 22;329(4):247-56. doi: 10.1056/NEJM199307223290406.
6
Free radicals, antioxidants, and endothelial cell damage after percutaneous transluminal coronary angioplasty.
Coron Artery Dis. 1993 Oct;4(10):905-10. doi: 10.1097/00019501-199310000-00010.
7
Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study.
Lancet. 1993 Oct 23;342(8878):1007-11. doi: 10.1016/0140-6736(93)92876-u.
8
tPA fast by GUSTO.
Lancet. 1993 May 8;341(8854):1188. doi: 10.1016/0140-6736(93)91011-a.
9
Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine.
Lancet. 1993 Feb 20;341(8843):454-7. doi: 10.1016/0140-6736(93)90206-v.
10
Strategies of antioxidant defense.
Eur J Biochem. 1993 Jul 15;215(2):213-9. doi: 10.1111/j.1432-1033.1993.tb18025.x.
Zotero 插件